A detailed history of Advisor Group Holdings, Inc. transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,431 shares of INKT stock, worth $744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,431
Previous 1,431 -0.0%
Holding current value
$744
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.87 - $1.56 $444 - $797
511 Added 55.54%
1,431 $1,000
Q1 2024

May 10, 2024

BUY
$0.84 - $1.12 $527 - $703
628 Added 215.07%
920 $0
Q4 2023

Feb 12, 2024

SELL
$0.88 - $1.21 $96 - $133
-110 Reduced 27.36%
292 $0
Q3 2023

Nov 13, 2023

BUY
$1.1 - $2.09 $53 - $102
49 Added 13.88%
402 $0
Q2 2023

Aug 10, 2023

BUY
$0.89 - $3.33 $314 - $1,175
353 New
353 $0

Others Institutions Holding INKT

About MiNK Therapeutics, Inc.


  • Ticker INKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,775,100
  • Market Cap $17.6M
  • Description
  • MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...
More about INKT
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.